Assessment of reported adverse events after substitution between TNF alfa inhibitors biosimilars in the WHO pharmacovigilance database

被引：0

作者：

Orhon, P. ^{[1
]}

Robert, M. ^{[1
]}

Bernardeau, C. ^{[1
]}

Fusaroli, M. ^{[2
]}

Roustit, M. ^{[3
]}

Cracowski, J. L. ^{[1
]}

Khouri, C. ^{[1
]}

机构：

[1] Grenoble Alpes Univ Hosp, Pharmacovigilance Unit, Grenoble, France

[2] Dept Med & Surg Sci, Pharmacol Unit, Bologna, Italy

[3] Grenoble Alpes Univ Hosp, Clin Pharmacol Dept, Grenoble, France

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2023年 / 37卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PS-115

引用

页码：160 / 160

页数：1

共 50 条

[41] Differential Adverse Events Between TNF-α Inhibitors and IL-17 Axis Inhibitors for the Treatment of Spondyloarthritis [J].

Maria Antonelli ;

Muhammad A. Khan ;

Marina N. Magrey .

Current Treatment Options in Rheumatology, 2015, 1 (2) :239-254

[42] TNF-α inhibitors and psychiatric adverse drug reactions in the spectrum of bipolar (manic) or psychotic disorders: Analysis from the French pharmacovigilance database [J].

Yelnik, Cecile Marie ;

Gaboriau, Louise ;

Petitpain, Nadine ;

Theophile, Helene ;

Delaporte, Emmanuel ;

Carton, Louise ;

Gautier, Sophie ;

Lambert, Marc .

THERAPIE, 2021, 76 (05) :449-454

[43] Psoriasis after exposure to angiotensin converting enzyme inhibitors: Clinical features of a signal from the WHO pharmacovigilance database [J].

Azzouz, Brahim ;

Viguier, Manuelle ;

Trenque, Thierry .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (03) :653-655

[44] Hematologic adverse events reported after COVID-19 vaccination in the Philippines: A national database study [J].

Mesina, Flordeluna Z. ;

Sapinoso, Frances Alexandra D. ;

De Castro, Joy Ann V. ;

Vaswani, Preeti Prerna M. ;

Sy, Charles Eryll S. ;

Oquendo, Rizza Ann A. ;

Lirasan, Mark Ryann A. .

VACCINE, 2023, 41 (23) :3550-3555

[45] Exploring the correlation between cardiovascular adverse events and antidepressant use: A retrospective pharmacovigilance analysis based on the FDA Adverse Event Reporting System database [J].

Wang, Zhanzhang ;

Lu, Haoyang ;

Li, Yuandan ;

Huang, Shanqing ;

Zhang, Ming ;

Wen, Yuguan ;

Shang, Dewei .

JOURNAL OF AFFECTIVE DISORDERS, 2024, 367 :96-108

[46] Analysis of Predictors of Adverse Events and Mortality Risk Associated With IL-6 Inhibitors: A Pharmacovigilance Study Using the FDA Adverse Event Reporting System Database [J].

Fang, Meilin ;

Li, Jinglin ;

Zhuang, Boyang ;

Liang, Weijie ;

Wang, Ling ;

Wang, Cunze ;

Chen, Wujin ;

Cai, Fangqing ;

Ruan, Junshan ;

Huang, Zhuiliang ;

Jin, Yishun .

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2025, 2025 (01)

[47] Investigation of the total anticholinergic load of reported anticholinergic drug-related adverse events using the Japanese adverse drug event report database: a retrospective pharmacovigilance study [J].

Kan, Yusuke ;

Doi, Maki ;

Uesawa, Yoshihiro .

JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2025, 11 (01)

[48] Gender and age disparities in cardiac immune-related adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FAERS database [J].

Shan, Wenya ;

Zhu, Jieqiang ;

Shen, Jiayu .

BMJ OPEN, 2025, 15 (06)

[49] The Association between PDE5 Inhibitors and Aneurysm/Arterial Dissection : A Pharmacovigilance Study Using WHO Safety Database [J].

Miyata, Koji ;

Izawa-Ishizawa, Yuki ;

Niimura, Takahiro ;

Hamano, Hirofumi ;

Aizawa, Fuka ;

Yagi, Kenta ;

Kawada, Kei ;

Zamami, Yoshito ;

Goda, Mitsuhiro ;

Ishizawa, Keisuke .

JOURNAL OF MEDICAL INVESTIGATION, 2024, 71 (1-2) :134-140

[50] Reported congenital malformations after exposure to non-TNF- α inhibitors: A retrospective comparative study in eudravigilance database [J].

Ghalandari, Nafise ;

Crijns, Hubertina Johanna Maria Josephina ;

Bergman, Jorieke ;

Dolhain, Radboud ;

Van Puijenbroek, Eugene ;

Hazes, Mieke .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 :255-256

← 1 2 3 4 5 →